![](/img/cover-not-exists.png)
RealâWorld Outcomes of Patients with Metastatic NonâSmall Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval
Khozin, Sean, Carson, Kenneth R., Zhi, Jizu, Tucker, Melisa, Lee, Shannon E., Light, David E., Curtis, Melissa D., Bralic, Marta, Kaganman, Irene, Gossai, Anala, Hofmeister, Philip, Torres, Aracelis ZVolume:
24
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2018-0307
Date:
May, 2019
File:
PDF, 1.15 MB
2019